medigraphic.com
ISSN 1561-3127 (Electronic)
ISSN 0864-3466 (Print)

2021, Number 4

<< Back Next >>

Revista Cubana de Salud Pública 2021; 47 (4)

Characterization of SARS-CoV-2 infection in older adults in Cuba, March-June 2020

Suárez BB, Marcheco TB, Monzón BG, Roblejo BH, González TMÁ, Camayd VI, Rizo LD

Language: Spanish
References: 41
Page: 1-22
PDF size: 904.06 Kb.


ABSTRACT

Introduction: COVID-19 has the potential to impact any population group, however, older adults have a worse prognosis and a higher mortality rate.
Objective: Characterize the clinical-epidemiological variables of older adults with SARS-CoV-2 in the first three months of the epidemic in Cuba.
Methods: An observational cross-sectional study was conducted in Cuban patients aged 60 years and older, with epidemiological discharge of SARS-CoV-2 infection, between March 11 and June 11, 2020. A questionnaire with clinical and sociodemographic variables was applied. Statistical analyses were performed using the SPSS 22.0 statistical package.
Results: 241 patients were studied, 52.3 % presented mild or moderate symptoms. There was an increase in average age from asymptomatic to severe. Blood group O (46.1%) was the most frequent; however, those in group A showed an increased risk of developing symptoms. The most common associated diseases were high blood pressure, cardiovascular disease and diabetes mellitus. Fever, dry cough and shortness of breath were the most frequent symptoms.
Conclusions: Patients with blood group A, hypertensive patients and associated cardiovascular diseases presented an increased risk of suffering from symptomatic forms. The vulnerability of older adults comes not only from their age, but also from associated chronic diseases, which is why the protection of this population group is essential.


REFERENCES

  1. Promislow DEL. A Geroscience Perspective on COVID-19 Mortality. J Gerontol A BiolSci Med Sci.2020;75(9):e30-e33. DOI: 10.1093/gerona/glaa094.

  2. Canchari CR, Quispe Arrieta R, Huaman Castillon KM. COVID-19 y su relación con poblaciones vulnerables. Revhabanciencméd. 2020 [acceso 23/11/2020];19(0). Disponible en: http://www.revhabanera.sld.cu/index.php/rhab/article/view/3341

  3. Saavedra Hernández D, García Verdecia B. Inmunosenescencia: efectos de la edad sobre el sistema inmune. Rev Cubana Hematol Inmunol Hemoter. 2014 [acceso 01/10/2020];30(4):332-45. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-02892014000400005&lng=es

  4. Areces LópezA. Efectos biológicos y relevancia clínica de la inmunosenescencia.16 de Abril. 2020 [acceso 05/10/2020];59(277):e740. Disponible en: http://www.rev16deabril.sld.cu/index.php/16_04/article/view/740

  5. Barrera-Salas M, Morales-Hernández AE, Hernández-Osorio JJ, Hernández Salcedo DR, Valencia-López R, Ramírez-Crescencio MA, Inmuno-senescencia. Med Int Méx. 2017;33(5):696-704.DOI: 10.24245/mim.v33i5.1204

  6. Rozenek, M, Soengas N, Giber F Murgieri M.COVID-19 en adultos mayores: ¿corresponde usar la misma definición de caso? Rev. Arg. de Gerontología y Geriatría. 2020 [acceso 12/10/2020];34(1):1-6. Disponible en: http://www.sagg.org.ar/wp/wp-content/uploads/2020/04/RAGG_04_2020-3-6.pdf

  7. Porcel-Gálvez AM, Badanta B, Barrientos-Trigo S, Lima Serrano M. Personas mayores, dependencia y vulnerabilidad en la pandemia por coronavirus: emergencia de una integración Socialy sanitaria. Enferm Clin. 2021;31:S18-S23. DOI: 10.1016/j.enfcli.2020.05.004

  8. Porcheddu R, Serra C, Kelvin D, Kelvin N, Rubino S. Similarity in Case Fatality Rates (CFR) of COVID-19/SARS-COV-2 in Italy and China. J Infect Dev Ctries. 2020;14(2):125-28. DOI: 10.3855/jidc.12600

  9. Livingston E, Bucher K. Coronavirus Disease 2019 (COVID-19) in Italy. JAMA. 2020 [acceso 21/10/2020];323(14):1335. DOI: 10.1001/jama.2020.4344

  10. Minsap. Redacción Minsap. Parte de cierre del día 11 de junio a las 12 de la noche. La Habana: Minsap; 2020 [acceso 13/06/2020]. Disponible en:https://salud.msp.gob.cu/parte-de-cierre-del-dia-11-de-junio-a-las-12-de-la-noche/

  11. OMS. Manejo clínico de la COVID-19: orientaciones provisionales, 27 de mayo de 2020. Ginebra: Organización Mundial de la Salud; 2020. Disponible en: https://apps.who.int/iris/bitstream/handle/10665/332638/WHO-2019-nCoV-clinical-2020.5-spa.pdf?sequence=1&isAllowed=y

  12. Espinosa Brito Alfredo D, Romero Cabrera Ángel J, Espinosa Roca Alfredo A La geriatrización de los servicios y de los profesionales de la salud. Rev cubana med. 2009 [acceso 21/01/2021];48(4):135-8. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75232009000400001&lng=es

  13. Oficina Nacional de Estadística, Centro de Estudios de Población y Desarrollo. El Envejecimiento de la Población. Cuba y sus territorios-2019. La Habana: ONEI; 2020 [acceso 30/10/2020]. Disponible en:http://www.onei.gob.cu/sites/default/files/envejecimiento_completo.pdf

  14. Espinosa-Brito A. COVID-19: rápida revisión general. Anales de la Academia de Ciencias de Cuba. 2020 [acceso 21/01/2021];10(2). Disponible en: http://revistaccuba.sld.cu/index.php/revacc/article/view/828

  15. OPS. Boletín de la Cooperación Técnica Cuba: "Andar la Salud". 2020 julio-septiembre Parte 05 [acceso 20/10/2020];24(3). Disponible en: https://iris.paho.org/handle/10665.2/53149

  16. Pérez Rodríguez N, Remond Noa R, Torres Reyes A, Veranes Miranda A, Fernández Lorenzo JM, Oviedo Álvarez V, et al. Distribución de la población vulnerable a la enfermedad COVID-19 en La Habana, Cuba. Rev Cubana Hig Epidemiol. 2020 [acceso 21/01/2021];57(0). Disponible en: http://www.revepidemiologia.sld.cu/index.php/hie/article/view/371

  17. Karlberg J, ChongDSY, Lai WY. Do Men Have a Higher Case Fatality Rate of Severe Acute Respiratory Syndrome than Women Do? American Journal of Epidemiology. 2004;159(3):229-31.DOI:10.1093/aje/kwh056

  18. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et.al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020 [acceso 21/10/2020];15;395(10223):507-13. Disponible en: https://www.thelancet.com/action/showPdf?pii=S0140-6736%2820%2930211-7

  19. Channappanavar R, Fett C, Mack M, Ten Eyck PP, Meyerholz DK, Perlman S. Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection. Journal of Immunology. 2017;198(10):4046-53. DOI: 10.4049/jimmunol.1601896

  20. Perrotta F, Corbi G, Mazzeo G, Boccia M, Aronne L, D'Agnano V, et. al. COVID-19 and the elderly: insights into pathogenesis and clinical decision-making. Aging Clin Exp Res. 2020 [acceso 03/10/2020];32(8):1599-1608. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7298699/pdf/40520_2020_Article_1631.pdf

  21. Mauvais-Jarvis F. Aging, Male Sex, Obesity, and Metabolic Inflammation Create the Perfect Storm for COVID-19. Diabetes. 2020;69(9):1857-63. DOI: 10.2337/dbi19-0023

  22. Onder G, Rezza G, Brusaferro S. Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy. JAMA. 2020;323(18):1775-76. DOI: 10.1001/jama.2020.4683

  23. Akbar AN, Gilroy DW. Aging immunity may exacerbate COVID-19. Science. 2020 [acceso 06/11/2020];369(6501):256-57. Disponible en: https://pubmed.ncbi.nlm.nih.gov/32675364/

  24. Nikolich-Zugich J, Knox KS, Rios CT, Natt B, Bhattacharya D, Fain MJ. SARS-CoV-2 and COVID-19 in older adults: what we may expect regarding pathogenesis, immune responses, and outcomes. Geroscience. 2020 [acceso 23/10/2020];42(2):505-14. DOI: 10.1007/s11357-020-00186-0

  25. Mueller AL, McNamara MS, Sinclair DA. Why does COVID-19 disproportionately affect older people? Aging (Albany NY). 2020;12(10):9959-81. DOI: 10.18632/aging.103344.

  26. Oficina Nacional de Estadística, Centro de Estudios de Población y Desarrollo.El color de la piel según el censo de población y viviendas de 2012. La Habana: ONEI; 2016 [acceso 08/09/2020]. Disponible en: http://www.onei.gob.cu/sites/default/files/publicacion_completa_color_de_la_piel__0.pdf

  27. Price-Haywood EG, Burton J, Fort D, Seoane L. Hospitalization and Mortality among Black Patients and White Patients with Covid-19. New England Journal of Medicine. 2020;382(26):2534-43. DOI: 10.1056/NEJMsa2011686 Disponible en: https://www.nejm.org/doi/pdf/10.1056/NEJMsa2011686?articleTools=true

  28. Holmes L Jr, Enwere M, Williams J, Ogundele B, Chavan P, Piccoli T, et al. Black-White Risk Differentials in COVID-19 (SARS-COV2) Transmission, Mortality and Case Fatality in the United States: Translational Epidemiologic Perspective and Challenges. Int J Environ Res Public Health. 2020;17(12):4322. DOI: 10.3390/ijerph17124322

  29. Kim SJ, Bostwick W. Social Vulnerability and Racial Inequality in COVID-19 Deaths in Chicago. Health Educ Behav. 2020;47(4):509-13. DOI: 10.1177/1090198120929677

  30. Leaf Rebecca K, Al-SamkariHanny, Brenner Samantha K, GuptaShruti, LeafDavid E. ABO phenotype and death in critically ill patients with COVID-19. British Journal of Haematology. 2020 [acceso 30/10/2020];190(4):e181-e232. Disponible en: https://onlinelibrary.wiley.com/doi/epdf/10.1111/bjh.16984

  31. Pourali F, Afshari M, Alizadeh-Navaei R, Javidnia J, Moosazadeh M, Hessami A. Relationship between blood group and risk of infection and death in COVID-19: a live meta-analysis. New Microbes New Infect. 2020;37:100743. DOI: 10.1016/j.nmni.2020.100743

  32. Padhi S, Suvankar S, Dash D, Panda VK, Pati A, Panigrahi J, et al. ABO blood group system is associated with COVID-19 mortality: An epidemiological investigation in the Indian population. TransfusClin Biol. 2020 [acceso 16/11/2020];27(4):253-58. DOI: 10.1016/j.tracli.2020.08.009

  33. Zaidi FZ, Zaidi ARZ, Abdullah SM, Zaidi SZA. COVID-19 and the ABO blood group connection. Transfus Apher Sci. 2020;59(5):102838. DOI: 10.1016/j.transci.2020.102838

  34. Zhao J, Yang Y, Huang H, Li D, Gu D, Lu X, et al. Relationship between the ABO Blood Group and the COVID-19 Susceptibility. Clin Infect Dis.2020;4:ciaa1150. DOI: 10.1093/cid/ciaa1150

  35. Severe Covid-19 GWAS Group, Ellinghaus D, Degenhardt F, Bujanda L, Buti M, Albillos A, et al. Genomewide Association Study of Severe Covid-19 with Respiratory Failure. N Engl J Med. 2020;383(16):1522-34. DOI: 10.1056/NEJMoa2020283

  36. Ministerio de Salud Pública: Dirección de Registros Médicos y Estadísticas de Salud. Anuario Estadístico de Salud 2019. La Habana: Minsap; 2020 [acceso 08/09/2020]. Disponible en: https://files.sld.cu/bvscuba/files/2020/05/Anuario-Electr%C3%B3nico-Espa%C3%B1ol-2019-ed-2020.pdf

  37. Martos Pérez F, Luque del Pino J, Jiménez García N, Mora Ruiz E, Asencio Méndez C, García Jiménez JM. et al. Comorbidity and prognosticfactors on admission in a COVID-19 cohort of a general hospital. Rev Clin Esp. 2020:S0014-2565(20)30179-X. DOI: 10.1016/j.rce.2020.05.017

  38. Sanyaolu A, Okorie C, Marinkovic A, Patidar R, Younis K, Desai P, et al. Comorbidity and its Impact on Patients with COVID-19. SN Compr Clin Med. 2020Jun 25:1-8. DOI: 10.1007/s42399-020-00363-4

  39. Plasencia-Urizarri TM, Aguilera-Rodríguez R, Almaguer Mederos LE. Comorbilidades y gravedad clínica de la COVID-19: revisión sistemática y meta-análisis. Revhabanciencméd. 2020 [acceso 24/11/2020];19(0). Disponible en: http://www.revhabanera.sld.cu/index.php/rhab/article/view/3389

  40. Oficina Nacional de Estadística, Centro de Estudios de Población y Desarrollo. Encuesta Nacional de Envejecimiento de la Población 2017: Informe de resultados. La Habana: ONEI; 2019 Sep [acceso 09/11/2020]. Disponible en: http://www.onei.gob.cu/sites/default/files/0.enep-017_documento_completo_0.pdf

  41. Serra Valdés MA. COVID-19. De la patogenia a la elevada mortalidad en el adulto mayor y con comorbilidades. Rev haban cienc méd. 2020 [acceso 24/11/2020];19(3). Disponible en: http://www.revhabanera.sld.cu/index.php/rhab/article/view/3379




2020     |     www.medigraphic.com